From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

HARL
premium content

Harland & Wolff, still a short: the bear case, six of the best

At 19.5p, shares in Harland & Wolff (HARL) are down by almost a third since an early November ramp but the market cap is still £35 million and there are stacks of Bulletin Board Morons who reckon this is a time to pick up a bargain. One who is short points out 6 key points the bulls ignore.
SYME
premium content

When is a trading statement not a trading statement? The fraud Supply@ME Capital opines: Part 1

What profit or rather loss did the fraud Supply@ME Capital (SYME) make last year? What about sales? Assets under management at the sub scale asset manager Tradeflow? How little cash is left? Er…. Nobody has a scooby and that is even after a trading statement today from the fraudsters. If there was good news on any hard metrics, Supply would shout about it. Instead…
Bearcast
premium content

Tom Winnifrith Bearcast: Boohoo is it a buy or a short or just one to watch from the sidelines with beer and popcorn?

I start with walking to school with Joshua in the snow then cover being an insider (Kefi and Skinbiotherapeutics) and what it actually means. Then Mode Global (MODE), ouzo on my cornflakes again, folks were warned, Red Rock Resources (RRR) and its comical broker note, and finally today's trading statement from Boohoo.com (BOO)
CEY
premium content

Centamin – a “most welcomed” Egyptian Court judgment, still a gold recovery Buy

Centamin (CEY) has emphasised a “most welcomed” Egyptian Supreme Constitutional Court judgment and that “operations at Sukari Gold Mine remain unaffected and continue as normal”. So what’s the “most welcomed” news?
MSLH

Marshalls – “in-line with current market expectations”, but for how long does that mean?

Landscape, building and roofing products manufacturer and supplier Marshalls (MSLH) has issued a trading statement commencing that “revenue for the year ended 31 December 2022 was £719 million (2021: £589 million)” and including that it “expects to deliver adjusted profit before tax for the full year that is in-line with current market expectations”. The shares have currently responded up to around 325p, but why still far below the 500p+ of even last summer?
RRR
premium content

Red Rock Resources a ten bagger? LMFAO Mr broker

I write as a shareholder in Red Rock Resources (RRR). But the broker note below, today being trumpeted on twitter today by boss Andrew Bell is complete and utter bollocks. The idea that Red Rock shares could go from 0.26p to 2.60p is just fantasy. There is more chance of me getting lucky with you know who by the weekend than of this work of fiction proving any where near accurate.
GoldfishShark

Video: The Fed has lost control, of inflation, silver to $100, buy gold

Author and investor Don Durrett might be termed as a bit more of a conspiracy theorist than even our own Nigel Somerville He reckons that the financial media and government tend to release bullish information which is inaccurate and misleading.
SGZ
premium content

ScotGold – buried in today’s news is a cash crisis, hence current valuation insane

Scotgold (SGZ) has today served up a trading statement where the bad news is buried in a place nobody is meant to spot. One imagines that the only folks holding this stock are patriotic Saltire waving heroin addicts yakking on about how women with penises should be allowed to go into women’s prisons and share a changing room with your 13 year old daughter. Maybe our heavily subsidised friends in Scotland have not noticed the elephant in the room or maybe economics is not their strongest subject?
G4M
premium content

Gear4Music hits a bum note again – another warning

Another quarter goes by and another blow for long term Gear4Music (G4M) fan Malcolm Stacey, another profits warning. The real issue, as I have noted many times before, is the balance sheet.
MODE
premium content

My bearish view on Mode has proven to be correct as it can't secure further funding and the share price collapses again!

Writing bear pieces about any share tends not to make you very popular with people who are invested in that company, to the extent that some feel the need to engage in personal abuse, or even threats, so it is always nice to see your opinion ( and in this case, that of TW too) vindicated!
ROO
premium content

Keep avoiding Deliveroo shares

I have pretty much had the same view on Deliveroo (ROO) shares since its comedy IPO in 2021: by all means have a Deliveroo delivery a couple of times a year, but don’t buy the shares! I last said that in August when the shares were just below a one quid price and, despite lower bond yields and better larger cap markets since, the stock is still about the same price today. And you will not be surprised to know that today’s update is still banging on about how the online food delivery company will be profitable…at some point later this decade!

Bearcast
premium content

Tom Winnifrith Bearcast: But the Welsh Girlies are shite and nobody wants to watch them!

I start with the news that the Welsh women and men's soccer teams will now get equal pay. Does nobody understand economics any more? Then it is onto bitcoin and also Argo Blockchain (ARB). Then Advanced Oncotherapy (AVO) which sounds madder by the day. It certainly does not understand economics. Then nanosynth (NNN) and finally Omega Diagnostics (ODX). I wonder how this Saltire flying Scottish dickhead is doing these days? 
TRX

Tissue Regenix – argues distribution agreement ‘delight’. How’s that balance sheet now?

Regenerative medical device group Tissue Regenix (TRX) has announced it is “delighted to be partnering with Kingsung Medical”for the distribution of OrthoPure XT in China. With its shares currently up by more than 7% on the day at 0.69p – with so many in issue, a £48.5 million market cap, what’s the significance?
EYE
premium content

Eagle Eye Solutions – argues “strong trading and confident outlook”, sufficient for the valuation?

Marketing technology group Eagle Eye Solutions (EYE) has issued a trading update including that it “is confident in delivering another year of profitable growth in line with its expectations”. But what does that mean in the context of a currently up to 542.5p share price?
EQT
premium content

EXPOSE: Whilst the structure of Eqtec related parties looks a concern, it is the business itself that would make me avoid it

A ShareProphets reader has asked me to take a look at Eqtec (EQT), which I’m happy to do as I’ve never exactly been a fan of the company, going back to 2019 when I last covered it.
Crime-Scene
premium content

BREAKING: Good news for Julie “Lingerie on Expenses” Meyer, the FCA fails us all again

A source close to the enquiry confirms that the FCA criminal investigation into Julie Meyer has been ended. She is a free woman. Well apart from that outstanding High Court arrest warrant and unpaid tax bills in the UK, Malta and America and an unsatisfied six figure personal guarantee to Barclays Bank.
EXR

Engage XR – “this coming year is set to be a seminal one”… but not for the reasons it suggests?

Describing itself as “a leading metaverse technology company”, Engage XR (EXR) has issued a trading update including emphasising “revenue for the group is expected to be €3.9m, an increase of 63% on 2021… cash collections in December being slightly ahead of schedule and revenue being better than expected in December”. So what of a current 4.525p share price, down from 13p as recently as last month?
BRBY
premium content

Busy day as Burberry, Currys and Ibstock chat with the market

A busy Wednesday for me. Thank goodness I was not invited to the Davos meeting in Switzerland. Firstly, luxury goods company Burberry (BRBY).
AVO

Advanced Oncotherapy – Worth 156p, Hardman? You’re ‘Avin’ A Giraffe

Paid-for investment "research" prostitute Hardman has released an update on AIM-listed Advanced Oncotherapy (AVO). This means that 1) the company is desperate for cash (no surprises there!), 2) a placing is on the way and 3) that Crispin Odey is sweating over his multiple purchases at a premium at 25p per share when the shares were trading below the 25p par price, given that they are now worth just 11.25p per share. I have much time for Odey, but he has surely called this one spectacularly wrong on multiple occasions.
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 10:46:04